114 related articles for article (PubMed ID: 6204681)
1. Hybridoma antibodies to human von Willebrand factor. II. Relative role of intramolecular loci in mediation of platelet adhesion to the subendothelium.
Meyer D; Baumgartner HR; Edginton TS
Br J Haematol; 1984 Aug; 57(4):609-20. PubMed ID: 6204681
[TBL] [Abstract][Full Text] [Related]
2. Characterization of 25 monoclonal antibodies to factor VIII-von Willebrand factor: relationship between ristocetin-induced platelet aggregation and platelet adherence to subendothelium.
Stel HV; Sakariassen KS; Scholte BJ; Veerman EC; van der Kwast TH; de Groot PG; Sixma JJ; van Mourik JA
Blood; 1984 Jun; 63(6):1408-15. PubMed ID: 6426553
[TBL] [Abstract][Full Text] [Related]
3. Shear rate dependent inhibition of platelet adhesion and aggregation on collagenous surfaces by antibodies to human factor VIII/von Willebrand factor.
Baumgartner HR; Tschopp TB; Meyer D
Br J Haematol; 1980 Jan; 44(1):127-39. PubMed ID: 6769457
[TBL] [Abstract][Full Text] [Related]
4. Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion.
Turitto VT; Weiss HJ; Zimmerman TS; Sussman II
Blood; 1985 Apr; 65(4):823-31. PubMed ID: 3872140
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of a monoclonal antibody to von Willebrand factor as a potent inhibitor of ristocetin-mediated platelet interaction and platelet adhesion.
Jorieux S; de Romeuf C; Samor B; Goudemand M; Mazurier C
Thromb Haemost; 1987 Jun; 57(3):278-82. PubMed ID: 3116700
[TBL] [Abstract][Full Text] [Related]
6. Von Willebrand factor in the vessel wall mediates platelet adherence.
Stel HV; Sakariassen KS; de Groot PG; van Mourik JA; Sixma JJ
Blood; 1985 Jan; 65(1):85-90. PubMed ID: 3917314
[TBL] [Abstract][Full Text] [Related]
7. [Von Willebrand factor and platelet adhesion to the subendothelium of the vascular wall].
Meyer D
Nouv Rev Fr Hematol (1978); 1982; 24(3):145-51. PubMed ID: 6752879
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody to human platelet glycoprotein I. II. Effects on human platelet function.
Ruan C; Tobelem G; McMichael AJ; Drouet L; Legrand Y; Degos L; Kieffer N; Lee H; Caen JP
Br J Haematol; 1981 Dec; 49(4):511-9. PubMed ID: 6797459
[TBL] [Abstract][Full Text] [Related]
9. Hybridoma antibodies to human von Willebrand factor. I. Characterization of seven clones.
Meyer D; Zimmerman TS; Obert B; Edgington TS
Br J Haematol; 1984 Aug; 57(4):597-608. PubMed ID: 6204680
[TBL] [Abstract][Full Text] [Related]
10. [Studies on the effects of five monoclonal antibodies, polyclonal rabbit antibody and homologous antibody to human F VIII/vWF on ristocetin-induced platelet agglutination and platelet retention by glass bead column].
Ogata K; Minami S; Kamiya T
Rinsho Ketsueki; 1985 Jul; 26(7):1042-9. PubMed ID: 2414486
[No Abstract] [Full Text] [Related]
11. Characterization of murine anti-glycoprotein Ib monoclonal antibodies that differentiate between shear-induced and ristocetin/botrocetin-induced glycoprotein Ib-von Willebrand factor interaction.
Cauwenberghs N; Ajzenberg N; Vauterin S; Hoylaerts MF; Declerck PJ; Baruch D; Deckmyn H
Haemostasis; 2000; 30(3):139-48. PubMed ID: 11014964
[TBL] [Abstract][Full Text] [Related]
12. A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor.
Bovill EG; Ershler WB; Golden EA; Tindle BH; Edson JR
Am J Clin Pathol; 1986 Jan; 85(1):115-23. PubMed ID: 3079626
[TBL] [Abstract][Full Text] [Related]
13. Adhesion of platelets to human artery subendothelium: effect of factor VIII-von Willebrand factor of various multimeric composition.
Sixma JJ; Sakariassen KS; Beeser-Visser NH; Ottenhof-Rovers M; Bolhuis PA
Blood; 1984 Jan; 63(1):128-39. PubMed ID: 6418228
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of AJW200, a humanized monoclonal antibody to von Willebrand factor, in monkeys.
Kageyama S; Yamamoto H; Nakazawa H; Matsushita J; Kouyama T; Gonsho A; Ikeda Y; Yoshimoto R
Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):187-92. PubMed ID: 11788481
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of factor VIII-von Willebrand factor ristocetin cofactor activity by monoclonal antibodies.
Hornsey V; Micklem LR; McCann MC; James K; Dawes J; McClelland DB; Prowse CV
Thromb Haemost; 1985 Aug; 54(2):510-4. PubMed ID: 3878608
[TBL] [Abstract][Full Text] [Related]
16. Asialo von Willebrand factor enhances platelet adhesion to vessel subendothelium.
Bastida E; Monteagudo J; Ordinas A; De Marco L; Castillo R
Thromb Haemost; 1988 Aug; 60(1):30-4. PubMed ID: 3263711
[TBL] [Abstract][Full Text] [Related]
17. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
[TBL] [Abstract][Full Text] [Related]
18. Evidence that the arg1744 gly1745 asp1746 sequence in the GPIIb-IIIa-binding domain of von Willebrand factor is involved in platelet adhesion and thrombus formation on subendothelium.
Weiss HJ; Hoffmann T; Yoshioka A; Ruggeri ZM
J Lab Clin Med; 1993 Sep; 122(3):324-32. PubMed ID: 8409708
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the novel murine monoclonal anti-von Willebrand factor (vWf) antibody GUR76-23 which inhibits vWf interaction with alpha IIb beta 3 but not alpha v beta 3 integrin.
Yokoyama K; Handa M; Oda A; Katayama M; Fujimura Y; Murata M; Kawai Y; Watanabe K; Ikeda Y
Biochem Biophys Res Commun; 1997 May; 234(1):147-52. PubMed ID: 9168979
[TBL] [Abstract][Full Text] [Related]
20. An immunoradiometric assay for human factor VIII/von Willebrand factor (VIII:vWF) using a monoclonal antibody that defines a functional epitope.
Goodall AH; Jarvis J; Chand S; Rawlings E; O'Brien DP; McGraw A; Hutton R; Tuddenham EG
Br J Haematol; 1985 Apr; 59(4):565-77. PubMed ID: 2580547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
